Tweet DURHAM, N.C., BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, today announced it raised $11.5 million in new funding.

To export BioSkryb funding data to PDF and Excel, clickClick here for more funding data on BioSkrybTo export BioSkryb funding data to PDF and Excel, click here This Seed round was led by venture capital firm Anzu Partners and included the law firm Wilson Sonsini Goodrich & Rosati.

BioSkryb's proprietary genomic amplification technology allows scientists working with scarce genetic material to achieve high quality gene sequencing data.

About BioSkrybBioSkryb is a venture-backed developer of genomic amplification technologies that deliver unprecedented coverage and fidelity for various gene sequencing applications.

Its proprietary genome amplification technology was developed at St. Jude Children's Research Hospital in Memphis, TN. | To read full story, visit https://startuparound.com/read/1578621607.405128/BioSkryb-Inks-$11.5M-Seed-Round?ref=audio_experience